Ant Group has co-led a $154m round for the medical payments technology provider, which came a year after a China Re-backed series A-plus.
China-based medical payments service MediTrust Health secured RMB1bn ($154m) in a series B round co-led by Ant Group, e-commerce group Alibaba’s financial services affiliate, on Friday.
Shanghai Biopharmaceutical Investment Fund, a vehicle for state-owned asset manager Shanghai Industrial Investment, and venture capital firm Sinovation Ventures also co-led the round, which included BioTrack Capital, Marathon Venture Partners and Northern Light Venture Capital.
The investor line-up was filled out by investment bank China Renaissance’s Huaxing Growth Capital unit and SAIF Partners China,…
